홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
KROS
#3561
Keros Therapeutics, Inc. Common Stock
11.740
0
USD
+1.65%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.65%
월간 변동
+6.24%
6달 변화
-22.25%
년간 변동율
-22.25%
이전 종가
11.550
0
Open
11.740
0
Bid
Ask
Low
11.715
0
High
11.740
0
양
5
마켓
주식
헬스케어
KROS
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
23.27 M
24 M
28.54 M
35.98 M
40.56 M
19.72 M
—
Valuation ratios
Enterprise value
1.38 B
1.17 B
1.03 B
1.22 B
82.17 M
114.03 M
-552.13 M
Price to earnings ratio
—
-23.22
-11.08
-8.29
-3.17
8.85
0.84
Price to sales ratio
—
67.92
—
8 410.96
166.94
3.16
10.08
Price to cash flow ratio
—
-21.97
-16.56
-10.2
-3.68
7.17
39.36
Price to book ratio
—
5.61
4.18
3.82
1.04
2.54
3.16
EBITDA 비율에 대한 기업 가치
-29.66
-20.97
-9.05
-7.22
-0.39
1.66
-60.71
Profitability ratios
Return on assets %
-0.17
-0.23
-0.34
-0.41
-0.3
0.26
0.07
Return on equity %
-0.17
-0.24
-0.38
-0.46
-0.33
0.29
0.07
Return on invested capital %
-8 687.99
-2 853.47
-2 576.22
-3 010.6
-3 115.77
811.36
762.3
Gross margin %
—
100
—
100
100
100
400
Operating margin %
—
-280.46
—
-112.54 K
-5 938.96
27.71
-7 958.72
EBITDA margin %
—
-278.58
—
-112 K
-5 904.34
28.25
-7 850.78
Net margin %
—
-292.26
—
-101.32 K
-5 277.55
35.68
-6 324.16
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
37.27
21.23
17.27
14.25
21.45
15.45
85.71
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.08
0
0
0.01
0.51
0.34
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-2.66
-2.78
-4.23
-4.3
2.84
2.56
EBIT per share
—
-2.42
-4.55
-5.77
-5.63
1.78
1.57
EBITDA per share
—
-2.4
-4.52
-5.74
-5.6
1.82
1.61
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
9.86
11.06
11.25
14.96
7.59
59.22
Net current asset value per share
—
10.78
11.32
11.79
15.73
8.33
62.6
Tangible book value per share
—
10.42
10.99
11.28
15.27
8.01
60.5
Working capital per share
—
10.27
10.67
10.97
15
7.79
59.65
Book value per share
—
10.42
10.99
11.28
15.27
8.01
60.5
뉴스
Insmed (INSM) Soars 5.5%: Is Further Upside Left in the Stock?
KROS: Is the Discount Book Value a Value Trap?
KROS Stock: What to Know About Rinvatercept in DMD
KROS Pipeline Catalysts: DMD Phase II and ALS Plans for 2026
Can Keros Therapeutics Rinvatercept Stand Out in the DMD Market?
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Keros Therapeutics, Inc. (KROS) Reports Q4 Loss, Misses Revenue Estimates
Keros Q1 실적, 수익 에상치보다 저조
Keros earnings missed by $0.16, revenue fell short of estimates
Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings?
Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results?
SRPT Stock Up 8% on Positive Long-Term Data From Elevidys Study in DMD